Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapleural paclitaxel for malignant pleural effusions secondary to ovarian, breast or lung cancer
2007-003664-22Phase 2Completed
- Sponsor
- Istituto Oncologico Veneto
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in malignant pleural effusion (MPE), ovarian cancer, breast cancer and 2 more, sponsored by Istituto Oncologico Veneto. Primary endpoint: Percentage of efficacy. Started Jun 2007; status: completed.
02
Drugs
paclitaxel
03
Conditions
malignant pleural effusion (MPE)ovarian cancerbreast cancerbronchial carcinomapleural carcinomatosis
Beyond the preview
Go deeper on 2007-003664-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003664-22.